Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have agreed to take part and given your written consent
- A heart scan (echocardiogram) has shown that your heart's pumping strength is between 15% and 40% (lower than normal)
- You have been diagnosed with heart failure with symptoms ranging from mild (noticeable during everyday activity) to severe (present even at rest)
Who may not be able to join:
- Your heart failure is caused by a blockage in the main outlet of the heart's left pumping chamber
- You have had a heart attack in the last 30 days
- You have a history of dangerous, potentially recurring abnormal heart rhythms, have been resuscitated, or have an implanted heart device to correct abnormal rhythms (ICD)
- You have had a stroke or another serious disabling condition within the last 3 months
- You have severe heart valve disease or are already scheduled for heart valve surgery
- Your kidneys are not working well enough (confirm with trial site)
- You have another serious illness that is expected to shorten your life
- You are unable to have a coronary angiogram (a heart X-ray using dye) or a specific type of heart MRI scan for any reason (confirm with trial site)
- You are currently taking part in another clinical trial
- After your medications have been fully adjusted, a special heart MRI shows no scar tissue on the heart, or your heart pumping strength has recovered to 50% or above
- The special heart MRI required before surgery was not completed in time before your scheduled operation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Antti Nykänen, Docent, Hospital District of Helsinki and Uusimaa
Phone: 050 427 0625
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in the amount of myocardial scar tissue; Change in plasma concentrations of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.